Form 4: Aethlon Medical Director Nicolas Gikakis Reports Acquisition of Shares and RSU Vesting

Director Nicolas Gikakis reported acquiring 32,894 shares of Aethlon Medical at $1.52 and vesting of restricted stock units (RSUs).

Summary

• On April 16, 2024, Nicolas Gikakis, a director of Aethlon Medical Inc., reported a transaction involving the company's common stock.
• Gikakis acquired 32,894 shares at a price of $1.52 per share.
• Following the transaction, Gikakis directly owns 46,574 shares of Aethlon Medical Inc.
• The reported transaction also involves restricted stock units (RSUs) that vest in four equal quarterly installments starting June 30, 2024, and ending March 31, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares by a director could be seen as a slightly positive signal, but it's not definitively bullish.

Positives

• The director's acquisition of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Aethlon Medical, AEMD, Form 4, Nicolas Gikakis, Director, Stock Acquisition, RSU Vesting, Beneficial Ownership